Am J Transplant, Volume 19, Suppl 3 Archives - Page 51 of 214 - ATC Abstracts

2019 American Transplant Congress
The Comparison of Glycemic Profiles during Post-Operative Early Period between Liver and Kidney Transplantation Assessed by Continuous Glucose Monitoring System
H. Yu¹, H. Jin², S. Lee², J. Yang¹, S. Park², S. Ahn¹, H. Hwang¹
¹Surgery, Chonbuk National University Medical School and Hospital, Jeonju, Korea, Republic of, ²Internal Medicine, Chonbuk National University Medical School and Hospital, Jeonju, Korea, Republic of
*Purpose: Newly developed hyperglycemia and worsening of previously well controlled glucose control are common after transplantation because of stressful condition and immunosuppressive agents including of…
2019 American Transplant Congress
Consistent High Burden of Arteriosclerosis in Pediatric Kidney Transplant Recipients
K. Ostendorf¹, N. Memaran¹, B. Borchert-Mörlins¹, J. von der Born¹, E. Bauer¹, A. von Wick¹, J. Oh², M. J. Kemper³, R. Büscher⁴, B. M. Schmidt⁵, A. Melk¹
¹Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany, ²Pediatric Nephrology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, ³Department of Pediatrics, Asklepios Klinik Nord - Heidberg, Hamburg, Germany, ⁴Pediatric Nephrology, University Hospital, Essen, Germany, ⁵Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
*Purpose: The second most common cause of death in pediatric kidney transplant (KT) recipients are cardiovascular (CV) diseases. We have previously shown that pulse wave…
2019 American Transplant Congress
En Bloc Kidney Transplant from Infant Donors Less Than 5kg into Adult Recipients
Z. Wang, Q. Xia, M. Wang, H. Li, J. Liu, J. Liu, J. Liu
Urology, Union hospital, Wuhan, China
*Purpose: To explore the feasibility of en bloc kidney transplantation from infant donors less than 5kg into adult recipients.*Methods: A retrospective analysis was conducted of…
2019 American Transplant Congress
Protocol Cidofovir for Refractory Polyomavirus Associated Nephropathy in Kidney Transplant Recipients
J. Clark, A. Haririan
University of Maryland Medical Center, Baltimore, MD
*Purpose: Dose-limiting nephrotoxicity has historically precluded the use of cidofovir for polyomavirus associated nephropathy (PVAN). With incidence of BK viremia in kidney transplant recipients increasing…
2019 American Transplant Congress
Share 21 Rather Than Share 15: Balancing Transplant Opportunity without Compromising Waitlist Outcomes
S. Nagai¹, L. C. Chau¹, M. Abouljoud¹, K. Collins¹, S. Jafri², M. Safwan¹, D. Moonka²
¹Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, ²Gastroenterology, Henry Ford Hospital, Detroit, MI
*Purpose: We recently reported that, with the introduction of Meld-Na liver allocation, the score at which patients clearly benefit from liver transplant as opposed to…
2019 American Transplant Congress
Liver Transplantation in Acute Hepatic Insufficiency Induced by Imatinib
A. I. David¹, D. N. Alvarenga de Rezende², M. C. Fantauzzi³, T. Di Santi³, N. C. Confuorto³, G. T. Martinho³, P. S. Antunes³
¹GI Surgery/Transplant, Hospital Samaritano de Sao Paulo, Sao Paulo, Brazil, ²GI Surgery/Transplant, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Sao Paulo, Brazil, ³Faculdade de Ciências Médicas da Santa Casa de São Paulo, Sao Paulo, Brazil
*Purpose: Case report of a Woman, pediatrician, 40 yo,with chronic myeloid leukemia using Imatinib who developed Serious Acute Hepatic Failure and needed liver transplant to…
2019 American Transplant Congress
Biliary Atresia Patients Receiving Liver Transplantation Reflect Changing Birth Demographics in the United States between 1987-2018
R. Sindhi, K. Soltys, G. Mazariegos, G. Bond, A. Khanna, P. McKiernan
Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA
*Purpose: To review the multi-center US experience with liver transplantation (LT) for Biliary Atresia (BA)*Methods: We reviewed LT outcomes in children with BA in the…
2019 American Transplant Congress
Outcomes for Lung Transplantation Recipients with Non-Alcoholic Fatty Liver Disease
A. J. Trindade¹, P. Burkett¹, S. El-Chemaly¹, N. Hashemi², T. Thaniyavarn¹, H. R. Mallidi³, H. J. Goldberg¹
¹Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, ²Gastroenterology and Hepatology, Brigham and Women's Hospital, Boston, MA, ³Division of Thoracic and Cardiovascular Surgery, Brigham and Women's Hospital, Boston, MA
*Purpose: Non-alcoholic Fatty Liver Disease (NAFLD) afflicts ~20-40% people in the western world and is a risk factor for comorbidities prevalent in the lung transplant…
2019 American Transplant Congress
Inadequate (ax) Transbronchial Biopsies Are Not Associated With Clad Or Death After Lung Transplantation
L. Levy¹, E. Huszti², J. Tikkanen³, R. Ghany³, S. Keshavjee³, T. Martinu³
¹Lung Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada, ²Biostatistics Research Unit, University Health Network, University of Toronto, Toronto, ON, Canada, ³Lung transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada
*Purpose: Acute cellular rejection (ACR) in lung transplantation is defined by perivascular and interstitial mononuclear infiltrates on lung allograft pathology. Procuring a good quality transbronchial…
2019 American Transplant Congress
Tracheostomy Following Liver Transplantation
J. Almario, O. Okoye, M. Spaggiari, K. Jacob, P. Di Cocco, E. Benedetti, I. Tzvetanov
Surgery, University of Illinois at Chicago, Chicago, IL
*Purpose: With the current demand for liver transplantation, sicker patients are frequently transplanted. These patient are at a higher risk of significant morbidity following surgery,…